U.S. Markets closed

Mind Medicine (MindMed) Inc. (MNMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.4400+0.0400 (+1.67%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.4000
Open2.4100
Bid2.4400 x 900
Ask2.4700 x 3200
Day's Range2.3700 - 2.4700
52 Week Range0.5510 - 5.7700
Volume2,881,454
Avg. Volume4,613,553
Market Cap552.221M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateMar 30, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.50
  • PR Newswire

    MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration

    Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that Dr. Matthias Liechti presented data from several ongoing studies at the INSIGHT Conference in Berlin, Germany. These investigator-initiated studies are being conducted as part of MindMed's ongoing collaboration with the UHB Liechti Lab.

  • CNW Group

    MindMed Announces Participation at Upcoming Investor Conferences

    Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, today announces that Robert Barrow, Chief Executive Officer of MindMed, will participate in the following investor conferences:

  • PR Newswire

    MindMed to Present at H.C. Wainwright 23rd Annual Global Investment Conference

    Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that Robert Barrow, Chief Executive Officer of MindMed, will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021. Members of management will also be available to speak with institutional investors in one-on-one virtual meetings throughout the conference.